We are pleased to present two Journal of Hematology & Oncology thematic series:
- Emerging agents and regimens for cancer therapy 2020
- Bi-specific T-cell engagers (BiTE) and antibody-drug conjugates (ADCs) for cancer therapy
The series are now closed to new submissions.